Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Hebert

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Annals of Pharmacotherapy|July 20, 1999
Diltiazem increases tacrolimus concentrationsM F Hebert, A Y Lam
The Annals of Pharmacotherapy|October 1, 1993
Endstage liver disease associated with nitrofurantoin requiring liver transplantationM F Hebert, J P Roberts
DICP : the Annals of Pharmacotherapy|July 1, 1990
What is the clinical role of aerosolized ribavirin?M F Hebert, B J Guglielmo
Clinical Pharmacology and Therapeutics|April 16, 2016
Pregnancy-related pharmacokinetic changesY Tasnif, J Morado, M F Hebert
Clinical Pharmacology and Therapeutics|March 1, 1996
The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteersT Chang, L Z Benet, M F Hebert
Clinical Pharmacology and Therapeutics|November 1, 1992
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme inductionM F Hebert, J P Roberts, T Prueksaritanont, et al.
Transplantation Proceedings|December 1, 1991
Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patientsM F Hebert, N L Ascher, J R Lake, et al.
Journal of Clinical Pharmacology|February 13, 1999
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteersM F Hebert, R M Fisher, C L Marsh, et al.
The Pharmacogenomics Journal|May 12, 2016
Prenatal pharmacogenomics: a promising area for researchE H Dorfman, E Y Cheng, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|July 1, 1995
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporineD Y Gomez, V J Wacher, S J Tomlanovich, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|July 20, 1999
Diltiazem increases tacrolimus concentrationsM F Hebert, A Y Lam
The Annals of Pharmacotherapy|October 1, 1993
Endstage liver disease associated with nitrofurantoin requiring liver transplantationM F Hebert, J P Roberts
DICP : the Annals of Pharmacotherapy|July 1, 1990
What is the clinical role of aerosolized ribavirin?M F Hebert, B J Guglielmo
Clinical Pharmacology and Therapeutics|April 16, 2016
Pregnancy-related pharmacokinetic changesY Tasnif, J Morado, M F Hebert
Clinical Pharmacology and Therapeutics|March 1, 1996
The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteersT Chang, L Z Benet, M F Hebert
Clinical Pharmacology and Therapeutics|November 1, 1992
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme inductionM F Hebert, J P Roberts, T Prueksaritanont, et al.
Transplantation Proceedings|December 1, 1991
Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patientsM F Hebert, N L Ascher, J R Lake, et al.
Journal of Clinical Pharmacology|February 13, 1999
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteersM F Hebert, R M Fisher, C L Marsh, et al.
The Pharmacogenomics Journal|May 12, 2016
Prenatal pharmacogenomics: a promising area for researchE H Dorfman, E Y Cheng, M F Hebert, et al.
Clinical Pharmacology and Therapeutics|July 1, 1995
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporineD Y Gomez, V J Wacher, S J Tomlanovich, et al.
Pageof 3